The changing spectrum of rheumatic disease in HIV infection

37Citations
Citations of this article
58Readers
Mendeley users who have this article in their library.

Abstract

Background: Rheumatic manifestations were described soon after human immunodeficiency virus (HIV) was discovered. Since however, combination anti-retroviral therapy (cART) has revolutionized the course of the infection. Less clear is what effect cART has had on rheumatic manifestations. Sources of data: References were retrieved from the PubMed database using keywords including: 'HIV' and 'arthritis'; 'myalgia'; 'arthralgia' and other disease-specific terms, e.g. 'rheumatoid arthritis'. Areas of agreement: Musculoskeletal pain was common in HIV and increased with AIDS. Immune restoration inflammatory syndrome on initiation of cART causes de novo autoimmune inflammatory rheumatic disorders. Seronegative inflammatory arthritis with/without axial involvement has been reported widely with HIV. Areas of controversy: It is unclear if HIV causes these conditions, creates an environmental milieu supportive of these conditions or acts as a marker of other risk factors. It is unclear what effect cART has had on these conditions. Growing points: Variable diagnostic classification criteria have caused this literature to be poorly comparable. Areas timely for developing research: High-quality controlled epidemiological studies using standardized criteria are needed among cART users. Treatment of active autoimmune disease in HIV patients needs to be evaluated formally. © 2012 The Author.

Cite

CITATION STYLE

APA

Lawson, E., & Walker-Bone, K. (2012, September). The changing spectrum of rheumatic disease in HIV infection. British Medical Bulletin. https://doi.org/10.1093/bmb/lds022

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free